Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular Degraders. | J Am Chem Soc | 2025 | 40506832 | PubTator, text mining | PubMed |
| In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation. | J Am Chem Soc | 2025 | 40493706 | PubTator, text mining | PubMed |
| Accommodating Statistical and Physics-Based Computational Protocols for Molecular Glue Model and Evaluation. | J Chem Inf Model | 2025 | 40492588 | PubTator, text mining | PubMed |
| CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights. | Front Immunol | 2025 | 40463393 | PubTator, text mining | PubMed |
| The contribution of cyclic imide stereoisomers on cereblon-dependent activity. | Chem Sci | 2025 | 40443985 | PubTator, text mining | PubMed |
| Guidance on the interpretation of CRBN mutations in myeloma. | Blood | 2025 | 40440041 | PubTator, text mining | PubMed |
| A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells. | Leukemia | 2025 | 40425803 | PubTator, text mining | PubMed |
| An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma. | Mediterr J Hematol Infect Dis | 2025 | 40375908 | PubTator, text mining | PubMed |
| SP1 promotes triple-negative breast cancer progression by targeting USP5. | Cancer Cell Int | 2025 | 40375299 | PubTator, text mining | PubMed |
| Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function. | Acta Pharm Sin B | 2025 | 40370550 | PubTator, text mining | PubMed |
| Targeting transcription factors through an IMiD independent zinc finger domain. | EMBO Mol Med | 2025 | 40369156 | PubTator, text mining | PubMed |
| Discovery of an LSD1 PROTAC degrader. | Proc Natl Acad Sci U S A | 2025 | 40366693 | PubTator, text mining | PubMed |
| Evaluation of anti-leukemic activity and underlying mechanisms of the novel GSPT1 degrader AB138 in acute myeloid leukemia. | Invest New Drugs | 2025 | 40366532 | PubTator, text mining | PubMed |
| Novel proteolysis-targeting chimera targeting RAD51 for the treatment of triple-negative breast cancer. | J Physiol Pharmacol | 2025 | 40350653 | PubTator, text mining | PubMed |
| Reductive C(sp2)-C(sp3) Coupling Protocol to Enable Linker Exploration of Cereblon E3-Ligase BRD4 Proteolysis-Targeting Chimeras. | J Med Chem | 2025 | 40340429 | PubTator, text mining | PubMed |
| Quantifying Cooperativity through Binding Free Energies in Molecular Glue Degraders. | J Chem Theory Comput | 2025 | 40326883 | PubTator, text mining | PubMed |
| Cellular parameters shaping pathways of targeted protein degradation. | Commun Biol | 2025 | 40316744 | PubTator, text mining | PubMed |
| Discovery of potent CRBN-recruiting epidermal growth factor receptor (EGFR) degraders in vitro. | Invest New Drugs | 2025 | 40301162 | PubTator, text mining | PubMed |
| Identification of E3 Ubiquitin Ligase Substrates Using Biotin Ligase-Based Proximity Labeling Approaches. | Biomedicines | 2025 | 40299435 | PubTator, text mining | PubMed |
| Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder. | Eur J Med Chem | 2025 | 40252382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=14